NCT04193657 Toward a Comprehensive Supportive Care Intervention for Older or Frail Men With mCRPC Status COMPLETED Phase N/A
NCT04179864 A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT04140526 Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04086966 PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study Status COMPLETED Phase PHASE1
NCT04085991 Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer Status TERMINATED Phase PHASE2
NCT04070209 Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04067713 Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04031378 Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer Status UNKNOWN Phase PHASE2
NCT04030338 Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04026230 Impact of Atorvastatin on Prostate Cancer Progression During ADT Status RECRUITING Phase PHASE3
NCT03977610 The Role of Ga68-PSMA-11 PET Imaging in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy Status COMPLETED Phase NA
NCT03939689 I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). Status COMPLETED Phase PHASE2
NCT03934164 Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO Status UNKNOWN Phase N/A
NCT03871816 A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer Status COMPLETED Phase N/A
NCT03867357 Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia Status COMPLETED Phase N/A
NCT03764540 Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide Status TERMINATED Phase PHASE2
NCT03763851 Cannabis Oil and Radiation Therapy for the Management of Pain Status TERMINATED Phase PHASE2
NCT03763253 Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03585114 Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers Status ACTIVE_NOT_RECRUITING Phase PHASE2